1. Home
  2. QTTB vs LEDS Comparison

QTTB vs LEDS Comparison

Compare QTTB & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • LEDS
  • Stock Information
  • Founded
  • QTTB 2015
  • LEDS 2005
  • Country
  • QTTB United States
  • LEDS Taiwan
  • Employees
  • QTTB N/A
  • LEDS N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • LEDS Semiconductors
  • Sector
  • QTTB Health Care
  • LEDS Technology
  • Exchange
  • QTTB Nasdaq
  • LEDS Nasdaq
  • Market Cap
  • QTTB 19.0M
  • LEDS 20.3M
  • IPO Year
  • QTTB N/A
  • LEDS 2010
  • Fundamental
  • Price
  • QTTB $1.92
  • LEDS $2.87
  • Analyst Decision
  • QTTB Hold
  • LEDS
  • Analyst Count
  • QTTB 8
  • LEDS 0
  • Target Price
  • QTTB $24.00
  • LEDS N/A
  • AVG Volume (30 Days)
  • QTTB 90.3K
  • LEDS 85.4K
  • Earning Date
  • QTTB 05-08-2025
  • LEDS 07-07-2025
  • Dividend Yield
  • QTTB N/A
  • LEDS N/A
  • EPS Growth
  • QTTB N/A
  • LEDS N/A
  • EPS
  • QTTB N/A
  • LEDS N/A
  • Revenue
  • QTTB N/A
  • LEDS $14,780,000.00
  • Revenue This Year
  • QTTB N/A
  • LEDS N/A
  • Revenue Next Year
  • QTTB N/A
  • LEDS N/A
  • P/E Ratio
  • QTTB N/A
  • LEDS N/A
  • Revenue Growth
  • QTTB N/A
  • LEDS 160.76
  • 52 Week Low
  • QTTB $1.38
  • LEDS $0.92
  • 52 Week High
  • QTTB $53.79
  • LEDS $3.16
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 57.55
  • LEDS 65.07
  • Support Level
  • QTTB $1.56
  • LEDS $2.54
  • Resistance Level
  • QTTB $1.96
  • LEDS $3.16
  • Average True Range (ATR)
  • QTTB 0.15
  • LEDS 0.28
  • MACD
  • QTTB 0.03
  • LEDS 0.04
  • Stochastic Oscillator
  • QTTB 87.80
  • LEDS 80.03

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

Share on Social Networks: